Annexon (ANNX) Cash & Equivalents (2019 - 2026)
Annexon (ANNX) reported Cash & Equivalents of $199.27 million for Q2 2026, up 49.5% from $133.32 million a year earlier and up 13.7% from the prior quarter.
Powered by 
Analysis
Annexon (ANNX) Cash & Equivalents (2019 - 2026) Analysis & Trends
At the end of FY2025, Annexon posted Cash & Equivalents of $162.05 million, up 220.7% from FY2024.
- Cash & Equivalents has a five-year compound annual growth rate of -9.6% (FY2020 to FY2025).
- By year, Cash & Equivalents came in at $50.53 million in FY2024 (-77.7%), $226.14 million in FY2023 (+60.3%), $141.05 million in FY2022 (+85.6%) and $76.01 million in FY2021 (-71.7%).
- The Q2 2026 figure ranks as the highest quarterly Cash & Equivalents since Q4 2023.
- Year over year, Cash & Equivalents has now increased in each of the last four quarters, with growth averaging 31.6% over the last eight quarters.
- The high point for year-over-year Cash & Equivalents in five years was Q4 2025 (growth of 220.7%); the low point was Q3 2021 (a decline of 81.5%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $175.21 million (Q1 2026), $162.05 million (Q4 2025) and $139.42 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Annexon | 719.37 Mn | 719.37 Mn | - | 199.27 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 199.27 Mn |
| Mar 31, 2026 | 175.21 Mn |
| Dec 31, 2025 | 162.05 Mn |
| Sep 30, 2025 | 139.42 Mn |
| Jun 30, 2025 | 133.32 Mn |
| Mar 31, 2025 | 98.15 Mn |
| Dec 31, 2024 | 50.53 Mn |
| Sep 30, 2024 | 80.57 Mn |
| Jun 30, 2024 | 158.34 Mn |
| Mar 31, 2024 | 152.97 Mn |
| Dec 31, 2023 | 226.14 Mn |
| Sep 30, 2023 | 134.19 Mn |
| Jun 30, 2023 | 114.65 Mn |
| Mar 31, 2023 | 145.15 Mn |
| Dec 31, 2022 | 141.05 Mn |
| Sep 30, 2022 | 211.69 Mn |
| Jun 30, 2022 | 105.65 Mn |
| Mar 31, 2022 | 112.83 Mn |
| Dec 31, 2021 | 76.01 Mn |
| Sep 30, 2021 | 68.52 Mn |
API Access
Annexon Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ANNX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "ANNX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ANNX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();